|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| Nutritional Supplements Delay the Progression of AIDS in HIV-Infected Patients not Receiving Antiretroviral Treatment According to the Harold Foster Foundation. |
|
|
Oct 30, 2009 |
498 |
| Highly active antiretroviral therapy too hard to swallow for HIV patients. |
|
|
Oct 26, 2009 |
396 |
| Treating HIV-AIDS with interleukin-2 'ineffective'. |
|
|
Oct 21, 2009 |
317 |
| HIV-1 treatment during pregnancy can prevent transmission to newborns. |
|
|
Oct 21, 2009 |
255 |
| Treating HIV-AIDS with interleukin-2 'ineffective'. |
|
|
Oct 18, 2009 |
317 |
| HIV-1 treatment during pregnancy can prevent transmission to newborns. |
|
|
Oct 18, 2009 |
255 |
| CytoDyn Transfers Research on Novel AIDS Drug to Massachusetts General Hospital. |
|
|
Oct 8, 2009 |
1344 |
| Impact of immunosuppression on radiographic features of HIV related pulmonary tuberculosis among Nigerians/Nijerya halkinda HIV ile iliskili bagisiklik sisteminin baskilanmasinin akciger tuberkulozunun radyolojik bulgularina etkileri. |
Desalu, Olufemi O.; Danfulani, Mohammed; Gambo, Z.; Salawu, Fatai; Damburam, Aliyu; Midala, Juliet |
Report |
Sep 1, 2009 |
2796 |
| Workforce participation increases with time on treatment. |
Leach-Lemens, Carole |
|
Sep 1, 2009 |
642 |
| New antiretroviral drug safe and effective for patients beginning HIV treatment. |
|
|
Aug 3, 2009 |
326 |
| HAART may help reduce mother-to-child HIV transmission. |
|
|
Aug 2, 2009 |
252 |
| Hypercoagulability due to protein S deficiency in HIV-seropositive patients. |
Orlovic, Dragana; Smego, Raymond A. |
Report |
Aug 1, 2009 |
2296 |
| Daily antiretroviral therapy may prevent mother-to-child HIV transmission. |
|
|
Jul 23, 2009 |
364 |
| Research and Markets: Forecast Insight Report: HIV - Cross-Class Fixed Dose Combinations Drive Continued Growth. |
|
|
Jul 20, 2009 |
365 |
| Weight gain predictive of survival in people on antiretroviral therapy. |
Safreed-Harmon, Kelly |
Report |
Jun 1, 2009 |
906 |
| Financial crisis threatens HIV treatment for 1.7 million. |
Alcorn, Keith |
|
Jun 1, 2009 |
646 |
| Cytheris Announces Publication of IL-7 Primate Study Showing Rapid and Massive T Cell Homing to the Gut. |
|
|
May 12, 2009 |
1558 |
| Early antiretroviral therapy can reduce deaths in HIV patients. |
|
|
Apr 15, 2009 |
395 |
| Early antiretroviral therapy can reduce deaths in HIV patients by 28pct. |
|
|
Apr 10, 2009 |
395 |
| Soon, HIV drug that may help patients not responding to treatment. |
|
|
Apr 1, 2009 |
482 |
| Variations in leprosy manifestations among HIV-positive patients, Manaus, Brazil. |
Talhari, Carolina; Matsuo, Christiane; Chrusciak-Talhari, Anette; de Lima Ferreira, Luis Carlos; Mir |
Report |
Apr 1, 2009 |
1154 |
| Cytheris Announces Publication of IL-7 HIV Data in The Journal of Clinical Investigation. |
|
|
Mar 17, 2009 |
1775 |
| HIV and the liver. |
Rockstroh, Jurgen |
Editorial |
Mar 1, 2009 |
1092 |
| The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta. |
Sturtevant, Doris; Preiksaitis, Jutta; Singh, Ameeta; Houston, Stan; Gill, John; Predy, Gerry; Fishe |
Report |
Mar 1, 2009 |
4139 |
| Data from ISENTRESS[R], Merck's HIV Integrase Inhibitor, in Patients Whose HIV is Controlled on a Lopinavir/Ritonavir-Based Therapy Presented at the 16th Conference on Retroviruses and Opportunistic Infections. |
|
Conference news |
Feb 9, 2009 |
8017 |
| Effect of free treatment and surveillance on HIV-infected persons who have tuberculosis, Taiwan, 1993-2006. |
Tseng, Shu-Hui; Jiang, Donald Dah-Shyong; Hoi, Hao-Seong; Lo, Hsiu-Yun; Hwang, Kao-Pin |
Report |
Feb 1, 2009 |
1620 |
| A cocktail for disaster: how mismanagement, slothful government and a tight state budget killed a pioneering AIDS fund for Illinois' black communities. |
Virella, Kelly |
|
Jan 1, 2009 |
3208 |
| Assessing risk of non-compliance to HAART: some practical considerations. |
Gardiner, Kim |
Report |
Dec 22, 2008 |
2282 |
| Shifting paradigms and emerging concepts in antiviral drug resistance. |
|
Brief article |
Dec 1, 2008 |
243 |
| Targeting the HIV integration process in antiviral therapy. |
McNeely, Melissa; Christ, Frauke; Thys, Wannes; Debyser, Zeger |
Clinical report |
Dec 1, 2008 |
8337 |
| 48TH annual ICAAC/IDSA 46th annual meeting, Washington DC, 25-28 October 2008. |
Das, Satyajit |
Conference news |
Dec 1, 2008 |
2815 |
| With antiretroviral drugs, life, with HIV, goes on. |
Hollander, Dore |
Brief article |
Dec 1, 2008 |
263 |
| High early mortality after starting antiretroviral treatment in Africa. |
|
Report |
Nov 1, 2008 |
621 |
| CytoDyn Files New IND For Cytolin(R). |
|
|
Oct 22, 2008 |
544 |
| Dust, sugar-cane and hip-hop: real world research in Africa. |
Hodgson, Ian |
|
Sep 22, 2008 |
2210 |
| Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS. |
|
|
Sep 4, 2008 |
612 |
| Vertical transmission rate is low when pregnant women get HIV therapy. |
Thomas, J. |
Clinical report |
Sep 1, 2008 |
848 |
| Neuroimaging of CNS involvement in HIV. |
Descamps, M.J.L.; Hyare, H.; Zerizer, I.; Jager, H.R. |
Report |
Sep 1, 2008 |
5284 |
| Malawi death rate down by 35%. |
Bateman, Chris |
Brief article |
Sep 1, 2008 |
273 |
| NanoViricides, Inc. Reports that HIVCide-I Was Significantly Superior to the Current Anti-HIV Three Drug Cocktail Standard. |
|
|
Aug 11, 2008 |
659 |
| Argos Therapeutics' Arcelis(TM) Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial. |
|
|
Aug 5, 2008 |
690 |
| Experts say AIDS should be tackled earlier. |
|
|
Aug 4, 2008 |
527 |
| Dual drug class resistance in two-thirds of those failing antiretroviral therapy in South Africa. |
Farham, Bridget |
Report |
Jul 1, 2008 |
581 |
| Arm of international once-daily HIV treatment trial stopped. |
Farham, Bridget |
Brief article |
Jul 1, 2008 |
226 |
| NanoViricides Anti-HIV Lead Drug Candidate Demonstrated Substantial Improvement in Survival Time in Animal Model. |
|
|
Jun 16, 2008 |
832 |
| CytoDyn to Meet with Quest Clinical Research to Finalize Phase II Strategy for Novel AIDS Drug. |
|
|
Jun 5, 2008 |
443 |
| Get out of jail, but keep taking your meds. |
|
Brief article |
Jun 1, 2008 |
234 |
| Monitor patients before treatment to improve survival in HIV. |
Farham, Bridget |
Report |
Apr 1, 2008 |
691 |
| Argos Therapeutics Presents Positive Phase 1 Safety Data for its Arcelis(TM) Platform in HIV at Keystone Symposia. |
|
|
Mar 31, 2008 |
785 |
| Quality of Life, As Important As Life Itself. |
|
|
Jan 17, 2008 |
380 |
| Implementation and effectiveness of antiretroviral therapy in Greenland. |
Lohse, Nicolai; Ladefoged, Karin; Obel, Niels |
|
Jan 1, 2008 |
2097 |
| A way to slow HIV? |
Hollander, Dore |
|
Dec 1, 2007 |
189 |
| 11th European Aids Conference, Madrid, Spain, 24-27 October 2007. |
Rusconi, Stefano |
|
Dec 1, 2007 |
2858 |
| Low rates of mother-to-child HIV transmission through breastmilk of women on antiretroviral therapy. |
|
|
Nov 1, 2007 |
340 |
| Hospitalisation of HIV positive pregnant women in USA before and after highly active antiretroviral therapy. |
|
Brief article |
Nov 1, 2007 |
202 |
| Antiretroviral therapy in HIV positive pregnant women and risk of pre-eclampsia, fetal death, preterm birth and low birthweight. |
|
|
Nov 1, 2007 |
434 |
| UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor. |
|
|
Oct 15, 2007 |
9780 |
| UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor. |
|
|
Oct 12, 2007 |
9768 |
| Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B. |
|
|
Oct 11, 2007 |
1648 |
| Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons. |
Martiniuk, Frank; Rao, Shaline D.; Rea, Thomas H.; Glickman, Michael S.; Giovinazzo, Jerome; Rom, Wi |
Letter to the editor |
Sep 1, 2007 |
1182 |
| An interesting case of first presentation CMV retinitis. |
Garvey, Lucy; Lamba, H.; Migdal, C.; Winston, A. |
Case study |
Sep 1, 2007 |
1740 |
| Prostate cancer in HIV-positive individuals: what we know and what we don't. |
Walters, Zoe; Shamash, Jonathan; Powles, Thomas |
Case study |
Sep 1, 2007 |
1325 |
| An HIV-associated mediastinal germ cell tumour complicated by acute myeloid leukaemia. |
Young, A.M.; Powles, T.; Holmes, P.; Wang, J.; Nelson, M.; Anderson, J.; Bower, M.D.; Brock, C.S. |
Case study |
Sep 1, 2007 |
2945 |
| Breast cancer in a woman with HIV/AIDS: case report and review of literature. |
Ashraff, Zohreen; Nallamala, Subali |
Case study |
Sep 1, 2007 |
1582 |
| A case series of HIV-positive patients with malignant melanoma. |
Webster, R.M.; Sarwar, N.; Price, H.; Bunker, C.B.; Brock, C.S. |
|
Sep 1, 2007 |
3711 |
| HIV Report Gives Detailed Analysis of the Antiretroviral Therapy Market. |
|
|
Jul 23, 2007 |
362 |
| How does hormonal contraception affect HIV therapy? |
Shears, Kathleen Henry |
Clinical report |
Jun 22, 2007 |
325 |
| Letrozole versus testosterone: a single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised estradiol levels. |
Rockstroh, Jurgen |
|
Jun 1, 2007 |
399 |
| Birth outcomes improve for HIV-exposed infants. |
Hollander, Dore |
|
Jun 1, 2007 |
210 |
| Examining the rollout of pediatric antiretroviral treatment in South Africa. |
|
|
May 1, 2007 |
1642 |
| Impact of HIV and highly active antiretroviral therapy on menstruation. |
|
Clinical report |
May 1, 2007 |
163 |
| Novel drugs highly effective in resistant HIV. |
Kirn, Timothy F. |
Clinical report |
May 1, 2007 |
603 |
| Ceasing HAART found not to cause neurocognitive decline in healthy patients. |
Bates, Betsy |
Clinical report |
May 1, 2007 |
503 |
| Paths of glory: pathways to wellness, a holistic health center in Boston, mixes up a different HIV cocktail. |
Henderson, William |
|
Apr 10, 2007 |
708 |
| GILEAD COMPLETES PHASE II OF HIV INTEGRASE INHIBITOR GS 9137. |
|
Clinical report |
Apr 1, 2007 |
370 |
| Survival with HAART. |
Lohse, N. |
Brief article |
Mar 1, 2007 |
178 |
| Gilead Announces Completion of Phase II Clinical Trial of Novel Investigational HIV Integrase Inhibitor GS 9137. |
|
Clinical report |
Feb 23, 2007 |
658 |
| Basic research paving way to clinical care; Efforts earn doctor Diabetes Association award. |
|
|
Feb 12, 2007 |
926 |
| Personalized Immunotherapy Clinical Trial Initiated in HIV Patients with Argos Therapeutics' AGS-004. |
|
|
Feb 9, 2007 |
525 |
| Care for HIV infection in the US: can we do better? |
Giordano, Thomas P. |
|
Jan 1, 2007 |
1296 |
| New approaches and resolve may define the future of the global HIV pandemic. |
Daar, Eric S. |
|
Jan 1, 2007 |
1524 |
| ONE person tests positive for HIV in Ireland every DAY; GET READY TO DO YOUR BIT AS GLOBE MARKS WORLD AIDS DAY. |
|
|
Dec 1, 2006 |
827 |
| Condom use among people living with HIV in Brazil. |
|
Brief article |
Nov 1, 2006 |
267 |
| Increased risk of pre-eclampsia and fetal death in HIV-positive pregnant women receiving HAART. |
|
Brief article |
Nov 1, 2006 |
59 |
| Decreasing pregnancy rates after IVF in HIV-positive women receiving HAART. |
|
Brief article |
Nov 1, 2006 |
100 |
| Ambrilia Biopharma and Merck & Co., Inc. Sign Licensing Agreement Granting Merck Worldwide Rights to Ambrilia's HIV/AIDS Protease Inhibitor Program. |
|
|
Oct 12, 2006 |
1140 |
| Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application for ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) to European Medicines Agency. |
|
|
Oct 9, 2006 |
3637 |
| REPEAT/Viral Suppression in Triple-Class Drug Resistant Patients Maintained after 24 Weeks of Treatment with MK-0518, an Investigational HIV Integrase Inhibitor, Plus Optimized Background Therapy (OBT). |
|
|
Oct 2, 2006 |
1150 |
| Viral Suppression in Triple-Class Drug Resistant Patients Maintained after 24 Weeks of Treatment with MK-0518, an Investigational HIV Integrase Inhibitor, Plus Optimized Background Therapy (OBT). |
|
|
Sep 29, 2006 |
1150 |
| Bristol-Myers Squibb and Gilead Sciences Establish Agreement to Commercialize ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) in Canada. |
|
|
Sep 28, 2006 |
2955 |
| Landmark Five-Year Data on Gilead's Anti-HIV Drug Viread(R) Presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy. |
|
Clinical report |
Sep 27, 2006 |
1667 |
| HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution. |
Sekhar, Rajagopal V. |
|
Sep 22, 2006 |
3410 |
| Bone problems and HIV: an interview with Steven Petak. |
|
Interview |
Sep 22, 2006 |
1394 |
| Women & HIV. |
|
|
Jun 1, 2006 |
2683 |
| Of microbicides & vaccines. |
|
|
Jun 1, 2006 |
783 |
| Even though new medications. |
|
Brief article |
Dec 22, 2005 |
151 |
| Chemokine receptors in anti-HIV therapy. |
Nichols, W. Garrett |
|
Jun 1, 2005 |
1937 |
| Alternative therapies for the holistic care of the HIV/AIDS patient. |
Bodkin, Candice |
|
Sep 1, 2003 |
5995 |
| Carbamazepine-Indinavir Interaction Causes Antiretroviral Therapy Failure. |
|
|
May 1, 2000 |
483 |
| Encouraging compliance among HIV patients. |
|
|
Aug 1, 1998 |
911 |
|
